MANCHESTER, England & DUBLIN--(BUSINESS WIRE)--Terebellum, the Ireland and UK-based subsidiary of AscellaHealth, a global healthcare and specialty pharmacy solutions company and a member of the AscellaHealth Family of Companies, heralds its international positioning with 2023 strategic planning sessions held in Manchester, UK and Dublin, Ireland to review synergies underway with pharmaceutical company partners and plan management training programs. Collaborating with The Brooks Group, an organization that deploys real science and real insights to deliver training that leads to increased sales and revenue, the Terebellum leadership team articulated the groundwork for go-forward robust operations.
To read more, Click Here.